Predicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques

Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI

(2019) Ali Ezzati et al.   Brain Imaging and Behavior

Neuropsychological latent classes at enrollment and postmortem neuropathology

(2019) Andrea R. Zammit et al.   Alzheimers & Dementia

Optimizing Machine Learning Methods to Improve Predictive Models of Alzheimer’s Disease

(2019) Ali Ezzati et al.   JOURNAL OF ALZHEIMERS DISEASE

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Big Data and Predictive Analytics

(2018) Nilay D. Shah et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cost-Effectiveness of the Use of Biomarkers in Cerebrospinal Fluid for Alzheimer's Disease

(2018) Cristina Valcárcel-Nazco et al.   JOURNAL OF ALZHEIMERS DISEASE

Identifying Cost-Effective Predictive Rules of Amyloid-β Level by Integrating Neuropsychological Tests and Plasma-Based Markers

(2018) Mona Haghighi et al.   JOURNAL OF ALZHEIMERS DISEASE

Class-Specific Incidence of All-Cause Dementia and Alzheimer’s Disease: A Latent Class Approach

(2018) Andrea R. Zammit et al.   JOURNAL OF ALZHEIMERS DISEASE

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms

(2018) Sebastian Palmqvist et al.   Alzheimers & Dementia

A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment

(2018) Si Eun Kim et al.   JOURNAL OF ALZHEIMERS DISEASE

Prediction of Cerebral Amyloid With Common Information Obtained From Memory Clinic Practice

(2018) Jun Ho Lee et al.   Frontiers in Aging Neuroscience

Predicting the Future — Big Data, Machine Learning, and Clinical Medicine

(2016) Ziad Obermeyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection

(2015) Stefan Teipel et al.   LANCET NEUROLOGY

Comment: Age effects on clinical trial results in Alzheimer dementia

(2015) H. R. Brashear   NEUROLOGY

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

(2015) Sebastian Palmqvist et al.   NEUROLOGY

Targeting Prodromal Alzheimer Disease With Avagacestat

(2015) Vladimir Coric et al.   JAMA Neurology

National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Lung Cancer Screening

(2015) Douglas E. Wood   Thoracic Surgery Clinics

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

(2014) Stephen Salloway et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

(2014) Rachelle S. Doody et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid

(2013) Susan M. Landau et al.   ANNALS OF NEUROLOGY

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

Amyloid-  Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods

(2012) S. M. Landau et al.   JOURNAL OF NUCLEAR MEDICINE

Comparisons of established risk prediction models for cardiovascular disease: systematic review

(2012) G. C. M. Siontis et al.   BMJ-British Medical Journal

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI

(2011) Leslie M. Shaw et al.   ACTA NEUROPATHOLOGICA

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

(2011) Eric Karran et al.   NATURE REVIEWS DRUG DISCOVERY

Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials

(2011) Joshua D Grill et al.   Alzheimers Research & Therapy

Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications

(2011) Robert Laforce et al.   Alzheimers Research & Therapy

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY